Incidence and risk factors for deep vein thrombosis among pediatric burn patients

Nouf Alturki1, Mohamed Alkahtani1, Mamoon Daghistani1

  • 1Department of Plastic and Reconstructive Surgery, National Guard Hospital, Jeddah, Saudi Arabia.

Insights

Pediatric burn patients face a high risk of deep vein thrombosis (DVT), particularly with large burns. Prolonged hospitalization and central lines are key risk factors, necessitating DVT screening and potential prophylactic anticoagulation.

Area of Science:

  • Pediatric critical care medicine
  • Vascular surgery
  • Burn management

Background:

  • Major burns significantly increase the risk of deep vein thrombosis (DVT) due to Virchow's triad.
  • Existing data on DVT incidence in pediatric burn patients is limited.
  • This study addresses the need for more information on DVT in this vulnerable population.

Purpose of the Study:

  • To determine the incidence of DVT in pediatric burn patients.
  • To identify risk factors associated with DVT development in pediatric burn patients.
  • To explore the necessity of prophylactic anticoagulation for pediatric burn patients.

Main Methods:

  • Retrospective chart review of 95 pediatric patients with second- and third-degree burns.
  • Inclusion criteria focused on burn severity and unit admission duration.
  • Exclusion criteria removed adult patients, minor burns, and specific surgical/trauma cases.

Main Results:

  • Overall thrombosis incidence was 4.2% (3.1% DVT, 1.1% arterial thrombosis).
  • Significant DVT risk factors included length of hospitalization (p=0.012), central venous catheter use (p=0.013), and % total body surface area (%TBSA) burned (p=0.004).
  • Pediatric DVT risk was not significantly associated with weight-for-age or BMI, unlike in adults.

Conclusions:

  • Extensive burns (≥40% TBSA) are a major DVT risk factor in pediatric patients.
  • Prolonged hospitalization and central venous catheters further elevate DVT risk.
  • Consider DVT investigation and prophylactic anticoagulation for pediatric burn patients with these risk factors, even if asymptomatic.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
261
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
312